Gene Editing Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

Endorsed with a plethora of applications in animal, plant, and cell line genetic engineering, gene editing market, in the recent years has received tremendous upsurge - the game-changing technology being one of the effective modes of editing mutations. Heavy R&D expenditures in this field to develop genetically modified plants as well as to facilitate researchers in developing targeted therapies for rare genetic diseases will significantly fuel the gene editing market demand over the coming years.

Request for a sample copy of this report @ www.gminsights.com/request-sample/detail/810

In this context, it wouldn’t be wrong to quote that enhanced healthcare facilities and the rising popularity of DNA insertion in genome of living organism are set to alter the growth dynamics of global gene editing market. A report by GMI, states that the overall gene editing industry is projected to hit USD 7.5 billion by 2024.

The animal genetic engineering segment accounted for US$785.4 million of the global gene editing industry in 2017 and is estimated to grow considerably through 2024. The growing implementation of products acquired from domestic animals has encouraged demand for gene editing technique. Additionally, widespread applications of gene editing techniques in animals have improved the quality of animal production. For example, gene editing techniques help in producing pigs that have a strong resistance capacity to a commonly known disease named Porcine Reproductive and Respiratory Syndrome (PRRS).

The Zinc Finger Nucleases (ZFNs) segment will witness significant growth on account of various advantages, including permanent and heritable mutations made by gene editing technology and escalated adoption in research and biotech industries. Reportedly, gene editing market share from ZFNs segment will observe a growth rate of 14.5% CAGR through 2024. ZFN nucleases play a vital role in gene editing processes and are useful to manipulate the genomes of various plants and animals.

With extensive investment for research and development in genetic editing technologies, the U.S. gene editing market will observe close to 14.5% CAGR up to 2024. According to the National Center for Advancing Translational Sciences report, for improving genome editing techniques, the National Institute of Health (NIH) got a whooping finding of US$86 million in 2018.

Also, the escalating prevalence of chronic conditions such as Alzheimer’s, cancer, and infectious ailments in the country is quite evident. For instance, in 2018, the Alzheimer’s Association estimated that nearly 5.7 million Americans of all ages are suffering from Alzheimer’s.

With extensive R&D funding, the presence of leading pharma companies, and various government initiatives, the China gene editing market is expected to witness considerable growth by 2024, and was valued atr US$154.6 million in 2017.

Leading companies in the global gene editing market include Recombinetics, Allele Biotech, Takara Bio, Precision Biosciences, CRISPR Therapeutics, Editas Medicine, DNA 2.0, Integrated DNA Technologies, Intellia Therapeutics, OriGene Technologies, Juno Therapeutics, Promega, Bio-Rad, and Addgene. 

Browse full table of contents (TOC) of this report @ www.gminsights.com/toc/detail/gene-editing-market

Partial Chapter of the Table of Content 

Chapter 4. Gene Editing Market, By Application

4.1. Key segment trends

4.2. Cell line engineering

4.2.1.  Market size, by region, 2013-2024 (USD Million)

4.3. Animal genetic engineering

4.3.1.  Market size, by region, 2013-2024 (USD Million)

4.4. Plant genetic engineering

4.4.1.  Market size, by region, 2013-2024 (USD Million)

4.5. Other applications

4.5.1.  Market size, by region, 2013-2024 (USD Million)

Chapter 5. Gene Editing Market, By Technology

5.1. Key segment trends

5.2. CRISPR/Cas9

5.2.1.  Market size, by region, 2013-2024 (USD Million)

5.3. Zinc Finger Nucleases (ZFNs)

5.3.1.  Market size, by region, 2013-2024 (USD Million)

5.4. TALENS

5.4.1.  Market size, by region, 2013-2024 (USD Million)

5.5. Others

5.5.1.  Market size, by region, 2013-2024 (USD Million)



Source link